Table 1 Demographic and Clinical Data of the Studied Sample

Patients

(N=96)

40/56

36.2 ± 12.2

(18–69)

12.4 ± 2.8

(8–20)

17.9 ± 11.3

(0–46)

50.5 ± 10.6

(25–77)

Comparison Ss

(N = 31)

15/16

40.3 ± 15.6

(19–70)

15.1 ± 2.9

(11–21)

3.3 ± 3.9

(0–12)

-

-

Group

Differences

Chi²(1) =

0.4

t(125) =

1.52, p > .1

t(125) = 4.69*

t(119) =

6.58**

Major Depressive

Disorder

(N=39)

21/18

42.4 ± 13.7

(18–69)

12.9 ± 2.9

(8–20)

23.8 ± 10.9

(1–46)

49.4 ± 9

(27–65)

None:2, N-Mix:15, AD-mix:3,

SSRI/SNRI:16, Natyp:1,

Benzo:1, MAO:1

Schizophrenia

(N = 32)

10/22

32.6 ± 9.1

(19–50)

12.7 ± 3.2

(8–18)

13.3 ± 9.7

(0–36)

49.1 ± 7.9

(34–69)

AD+N:15, AD:1, Atyp:13,

Typ:1, Mix-N:1 TCA:1

Drug Abuse

Drug Abuse

1/14

33 ± 9

(21–48)

10.9 ± 1.5

(8–13)

10.9 ± 8

(1–28)

59.9 ± 11.7

(36–77)

None:15

Personality

Disorder

(N=10)

8/2

27.9 ± 8.1

(18–43)

11.7 ± 1.4

(9–13)

21.4 ± 10.7

(6–44)

44.7 ± 15.4

(25–71)

None:5, Mix:1, TCA:1

Group

Differences

Chi2(3) =

17.42*

F(3,92) =

7.46**

F(3,92) =

2.2 n.s.

F(3,90) =

9.23**

F(3,89) =

5.95*